Literature DB >> 33339565

Reply.

Wenjie Ma1, Lisa L Strate2, Andrew T Chan3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33339565      PMCID： PMC7787192          DOI： 10.1016/j.cgh.2020.03.021

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  5 in total

1.  Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.

Authors:  Jost Langhorst; Sigrid Elsenbruch; Julia Koelzer; Andreas Rueffer; Andreas Michalsen; Gustav J Dobos
Journal:  Am J Gastroenterol       Date:  2007-10-04       Impact factor: 10.864

2.  Risk Factors of Diverticulitis With Special Reference to Inflammation.

Authors:  Tomoyuki Kawada
Journal:  Clin Gastroenterol Hepatol       Date:  2020-02-25       Impact factor: 11.382

3.  Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.

Authors:  Peter Laszlo Lakatos; Lajos Sandor Kiss; Karoly Palatka; Istvan Altorjay; Peter Antal-Szalmas; Eszter Palyu; Miklos Udvardy; Tamas Molnar; Klaudia Farkas; Gabor Veres; Jolan Harsfalvi; Janos Papp; Maria Papp
Journal:  Inflamm Bowel Dis       Date:  2010-09-23       Impact factor: 5.325

4.  Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.

Authors:  J Pugin; C C Schürer-Maly; D Leturcq; A Moriarty; R J Ulevitch; P S Tobias
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  Association Between Inflammatory Diets, Circulating Markers of Inflammation, and Risk of Diverticulitis.

Authors:  Wenjie Ma; Manol Jovani; Long H Nguyen; Fred K Tabung; Mingyang Song; Po-Hong Liu; Yin Cao; Idy Tam; Kana Wu; Edward L Giovannucci; Lisa L Strate; Andrew T Chan
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-08       Impact factor: 11.382
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.